What caused the after-hours gain in 4596.T stock?

The after-hours gain reflects pipeline optimism for emixustat and device updates, plus a surge in volume to 16,071,800 shares. Clinical milestones and investor commentary drove buying in the JPX listed Kubota Pharmaceutical.

What valuation and metrics should investors watch for 4596.T stock?

Watch **EPS -19.45**, trailing **PE -11.00**, **price to book 8.10**, and **cash per share JPY 27.93**. Also monitor upcoming earnings and clinical readouts for signals on valuation re-rating.

What is Meyka AI’s price forecast for 4596.T stock?

Meyka AI's forecast model projects a monthly price of **JPY 246.86**. Against the current **JPY 214.00**, that implies an upside of **15.36%**. Forecasts are model-based projections and not guarantees.

How should traders manage risk on 4596.T stock?

Given clinical and earnings risk, use scaled entries, tight stops near **JPY 178.00**, and target bands at **JPY 246.86** and **JPY 350.00** for aggressive plays. Position sizing is essential.

JP Stocks

4596.T Kubota Pharmaceutical (JPX) up 16.94% after hours 25 Feb 2026: catalysts to watch

ByHuzaifa Zahoor February 25, 2026February 25, 2026

The 4596.T stock surged 16.94% after hours on 25 Feb 2026, closing at JPY 214.00 on the JPX. Volume jumped to 16,071,800 shares, over twice the average daily flow. Traders flagged pipeline milestones and heavy intraday buying as drivers. We use Meyka AI’s data signals to explain why this move matters for both short-term traders and longer-term investors in Japan’s healthcare sector.